Kate moved to New Zealand ten years ago having trained in the U.K. and South Africa, where she was involved in clinical TB research and programme development. She works as an Infectious Diseases Physician in the Bay of Plenty. She is a member of the TB Clinical Network, a national body which advises on management of patients with Multi Drug Resistant TB and other similarly complex TB infections.
Multi- Drug Resistant TB - A Physicians Guide
So you think you have this TB case sorted out – then the lab phone with the GeneXpert report that states that molecular markers for Rifampicin resistance are detected. What does that mean? What are the implications for the patient and for your care of them? What might the future hold for the patient and how should they best be managed? Most importantly who will help you navigate this challenging path?
This session will answer these questions and explore the current state of MDR-TB in New Zealand along with the latest developments and treatment guidelines. Most importantly what is the TBCN and how can it help you?